Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 538

1.

Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.

Nakada M, Miyamori H, Yamashita J, Sato H.

Cancer Res. 2003 Jun 15;63(12):3364-9.

2.

Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.

Nakada M, Yamada A, Takino T, Miyamori H, Takahashi T, Yamashita J, Sato H.

Cancer Res. 2001 Dec 15;61(24):8896-902.

3.

Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases.

Miyamori H, Takino T, Kobayashi Y, Tokai H, Itoh Y, Seiki M, Sato H.

J Biol Chem. 2001 Jul 27;276(30):28204-11. Epub 2001 May 29.

4.

Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.

Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS.

Cancer Res. 1996 Jan 15;56(2):384-92.

5.

Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.

Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, Nagase H, Kashiwagi M, Soloway PD, DeClerck YA, Fridman R.

J Biol Chem. 2004 Mar 5;279(10):8592-601. Epub 2003 Dec 16.

6.

Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.

Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y.

Am J Pathol. 1999 Feb;154(2):417-28.

7.

Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs).

Lafleur MA, Handsley MM, Knäuper V, Murphy G, Edwards DR.

J Cell Sci. 2002 Sep 1;115(Pt 17):3427-38.

8.
12.

Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.

Lehti K, Valtanen H, Wickström SA, Lohi J, Keski-Oja J.

J Biol Chem. 2000 May 19;275(20):15006-13. Erratum in: J Biol Chem. 2004 Sep 17;279(38):40246.

13.

Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma.

Qin H, Moellinger JD, Wells A, Windsor LJ, Sun Y, Benveniste EN.

J Immunol. 1998 Dec 15;161(12):6664-73.

15.

Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas.

Groft LL, Muzik H, Rewcastle NB, Johnston RN, Knäuper V, Lafleur MA, Forsyth PA, Edwards DR.

Br J Cancer. 2001 Jul 6;85(1):55-63.

17.

Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.

Park HJ, Lee HJ, Min HY, Chung HJ, Suh ME, Park-Choo HY, Kim C, Kim HJ, Seo EK, Lee SK.

Eur J Pharmacol. 2005 Dec 19;527(1-3):31-6. Epub 2005 Nov 23.

PMID:
16309669
19.
20.

Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.

Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M, Sato H.

J Biol Chem. 2003 Oct 17;278(42):40764-70. Epub 2003 Aug 6.

Supplemental Content

Support Center